(NASDAQ: DTIL) Precision Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.33%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.92%.
Precision Biosciences's earnings in 2026 is -$52,732,000.On average, 7 Wall Street analysts forecast DTIL's earnings for 2026 to be -$101,860,775, with the lowest DTIL earnings forecast at -$119,829,387, and the highest DTIL earnings forecast at -$87,814,344. On average, 7 Wall Street analysts forecast DTIL's earnings for 2027 to be -$76,183,049, with the lowest DTIL earnings forecast at -$104,140,663, and the highest DTIL earnings forecast at -$44,921,529.
In 2028, DTIL is forecast to generate -$59,404,065 in earnings, with the lowest earnings forecast at -$80,607,578 and the highest earnings forecast at -$21,736,224.